Physician profile
Keneisha Smith
NPI 1760069447
$1,023.02
in general payments reported to CMS, 2019-2025
11 companies · $762 in 2025
The $762 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $261 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.59 | 2024-2025 | |
| Novo Nordisk INC | $164.85 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Sonex Health, INC. | $157.68 | 2025 | Sx-One Microknife |
| Lilly USA, LLC | $95.07 | 2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $90.04 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $64.97 | 2024-2025 | Farxiga, Airsupra |
| Xeris Pharmaceuticals, INC. | $44.38 | 2025 | Keveyis |
| Amgen INC. | $36.51 | 2025 | Otezla, Repatha |
| Astellas Pharma US INC | $34.26 | 2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $31.22 | 2025 | |
| Pfizer INC. | $25.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keneisha Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.